Digital Health Monthly: Scientific Webinar Series
Leveraging DHTs to Improve Data Collection and Analysis in Immunology Clinical Trials
Tuesday, January 28 @ 12 PM ET
Upcoming Digital Health Monthly:
Scientific Webinar Series
Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies
Tuesday, December 3 @ 12 PM ET
Digital Health Monthly: Scientific Webinar Series
Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.
As their adoption continues to grow, the ActiGraph team is excited to continue ‘Digital Health Monthly’, a monthly series of science-focused webinars to share the latest high-impact developments in clinical research from innovators in the digital health field. Each month, we feature brief data-driven presentations from clinical researchers, data scientists, and biostatisticians on a focused topic with dedicated time for audience Q&A. We believe that together, we can move the digital health technology field forward faster, and we are excited for this opportunity to facilitate important discussions on the latest research with members of the digital health community.
Patients with immunological diseases such as asthma, allergies, and autoimmune conditions suffer from mobility and physical activity constraints that have a negative impact on quality of life and make activities of daily living a challenge. Wearable digital health technology (DHTs) can collect valuable insights on this important aspect of patient functioning to modernize outcome measurements and accelerate drug development in immunological diseases.
In the first Digital Health Monthly session of 2025, we’ll be joined by Jie Shen, PhD, MBA, Research Fellow and Director, Digital Science at AbbVie, who will present “Profiling Physical Activities of Patients with Immunological Diseases.”
Dr. Shen will discuss AbbVie’s approach to addressing unmet needs in drug development in immunological diseases and share how their team uses DHTs in clinical trials for better data collection, analysis, and integration into research trials. He will share clinical validation data from DHTs used to measure physical activities in two patient populations.
Speakers
